Some uses of transition metal complexes as anti-cancer and anti-HIV agents

Raymond Wai-Yin Sun; Dik-Lung Ma; Ella Lai-Ming Wong; Chi-Ming Che

doi:10.1039/B705079H

skip RSC | ChemSpider | Feedback

Home > Journals > Dalton Transactions > Some uses of transition...

Authors & Referees | Librarians

You do not have JavaScript enabled. Please enable JavaScript to access the full features of the site or access our non-JavaScript page.

Dalton Transactions

Issue 43, 2007

More about this Journal
Editorial Board
Submit an Article

Follow Journal | |

Journal Home | RSC Journals

Perspective

Previous Article | Next Article

Some uses of transition metal complexes as anti-cancer and anti-HIV agents

Raymond Wai-Yin Sun , Dik-Lung Ma , Ella Lai-Ming Wong and Chi-Ming Che

Dalton Trans., 2007, 4884-4892

DOI: 10.1039/B705079H
Received 03 Apr 2007, Accepted 04 Jun 2007
First published on the web 18 Sep 2007
This article is part of the collection: Dalton Discussion 10: Applications of metals in medicine and healthcare

Please wait while Download options loads

Request Permissions

Abstract
Cited by
Related Content

The success of the clinical uses of cisplatin, cis-[Pt^II(NH₃)₂Cl₂], has stimulated considerable interest in using other metal complexes as new therapeutic agents. This perspective describes our recent work on several classes of gold(III), platinum(II), ruthenium(II, III, IV), iron(II) and vanadium(IV) complexes for anti-cancer and anti-HIV treatments.

Terms & Conditions|Privacy |Accessibility|ACAP Enabled

Dalton Transactions

Some uses of transition metal complexes as anti-cancer and anti-HIV agents

Log in (Free Access)

Log in (Subscriber Access)

Articles By